October 13, 2016
SpineGuard Reports €1.7M Revenue for 3Q 2016, and 9 Months Growth of 15%
SpineGuard announced today that its third quarter revenue grew to €1.7 million, a 2% increase compared with 3Q 2015.
Pharmaceuticals, Biotechnology and Life Sciences
Tag: Pierre Jérôme